Eric Leo Eisenstein

Conference Circulation · November 7, 2023 Introduction: TRANSFORM-HF trial showed no significant difference in mortality or hospitalization outcomes in patients randomized to torsemide (T) versus furosemide (F) following a heart failure (HF) ... Full text Cite

Abstract 14698: Effect of Torsemide vs. Furosemide Among Patients With New Onset and Worsening Heart Failure: The Transform-HF Randomized Trial

Conference Circulation · November 7, 2023 Introduction: In the TRANSFORM HF trial, among patients discharged after hospitalization for heart failure (HF), torsemide compared with furosemide did not result in a significant difference in all-ca ... Full text Cite

Comparative Effectiveness of Torsemide versus Furosemide in Heart Failure: Primary Results of the TRANSFORM-HF Trial

Conference CIRCULATION · December 20, 2022 Link to item Cite

Understanding facilitators and barriers to development and adoption of EHR-to-eCRF technology in multi-site clinical research.

Conference AMIA · 2020 Cite

IP059. Early and Late Costs of Endovascular Abdominal Aortic Aneurysm Repair From the Endurant Stent Graft System Post Approval Study (ENGAGE PAS)

Conference Journal of Vascular Surgery · June 2018 Full text Cite

ASSESSING THE FINANCIAL VALUE OF PATIENT ENGAGEMENT

Conference VALUE IN HEALTH · May 1, 2017 Link to item Cite

How to Teach Health IT Evaluation: Recommendations for Health IT Evaluation Courses.

Conference Stud Health Technol Inform · 2017 Systematic health IT evaluation studies are needed to ensure system quality and safety and to provide the basis for evidence-based health informatics. Well-trained health informatics specialists are required to guarantee that health IT evaluation studies a ... Link to item Cite

ACUTE AND LONG-TERM OUTCOMES IN OLDER DIABETIC PATIENTS RECEIVING A CORONARY STENT: CONTEMPORARY RESULTS IN 405,679 PATIENTS

Conference Journal of the American College of Cardiology · April 2011 Full text Cite

Cost-effectiveness of an Early Revascularization Strategy for Cardiogenic Shock Based on Long-term Outcomes

Conference CIRCULATION · November 3, 2009 Link to item Cite

Assessing proportions of higher-risk acute coronary syndrome-percutaneous coronary intervention patients in clinical trials and clinical practice

Conference CIRCULATION · May 27, 2008 Link to item Cite

Moderate obesity is associated with better intermediate-term survival in acute coronary syndromes: Results from the SYMPHONY and 2nd SYMPHONY clinical trials

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · March 19, 2003 Link to item Cite

The right test for the right price

Conference CIRCULATION · November 5, 2002 Link to item Cite

Eric Leo Eisenstein

Scholarly Works - Conferences

Abstract 14826: Effect of Torsemide vs Furosemide After Discharge for Acute Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: Observations From Transform-HF

Abstract 14698: Effect of Torsemide vs. Furosemide Among Patients With New Onset and Worsening Heart Failure: The Transform-HF Randomized Trial

Comparative Effectiveness of Torsemide versus Furosemide in Heart Failure: Primary Results of the TRANSFORM-HF Trial

Understanding facilitators and barriers to development and adoption of EHR-to-eCRF technology in multi-site clinical research.

IP059. Early and Late Costs of Endovascular Abdominal Aortic Aneurysm Repair From the Endurant Stent Graft System Post Approval Study (ENGAGE PAS)

ASSESSING THE FINANCIAL VALUE OF PATIENT ENGAGEMENT

How to Teach Health IT Evaluation: Recommendations for Health IT Evaluation Courses.

Identifying And Valuing Patient Group Engagement Methods

Platform for Engaging Everyone Responsibly (PEER) Validation Study Plan.

Torsemide vs. Furosemide in Heart Failure Patients: Insights from Duke University Hospital

Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without On-Site Cardiac Surgery

ACUTE AND LONG-TERM OUTCOMES IN OLDER DIABETIC PATIENTS RECEIVING A CORONARY STENT: CONTEMPORARY RESULTS IN 405,679 PATIENTS

Cost-effectiveness of an Early Revascularization Strategy for Cardiogenic Shock Based on Long-term Outcomes

Assessing proportions of higher-risk acute coronary syndrome-percutaneous coronary intervention patients in clinical trials and clinical practice

The economic return of performing pediatric anti-hypertensive drug clinical trials

Bleeding complications are a major driver of resource use among patients with acute coronary syndromes

Drug-eluting stent use is associated with significant improvements in long-term clinical outcomes

220: Local Cost Structures and the Economics of Robot Assisted Radical Prostatectomy

Assessing the economic attractiveness of coronary artery revascularization in chronic kidney disease patients

Is coronary artery revascularization associated with, increased life expectancy in chronic kidney disease patients?

Moderate obesity is associated with better intermediate-term survival in acute coronary syndromes: Results from the SYMPHONY and 2nd SYMPHONY clinical trials

The right test for the right price